EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. CRL

Equity Profile

CRL

Charles River Laboratories International, Inc.

Health CareLife Sciences Tools & Services$14.2B market cap

Earnings scorecard

Last 76Q

EPS beat streak

29Q

EPS beat rate

89%

Avg EPS surprise

+8.08%

Avg 1-day reaction

+0.28%

Earnings history

77 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingNov 4, 2026————Preview
Q2-2026Aug 5, 2026$2.74$3.02+10.99%+11.36%Preview
Q1-2026May 7, 2026$1.94$2.06+5.21%-0.03%Preview
Q4-2025Feb 18, 2026$2.33$2.39+2.49%-0.33%Preview
Q3-2025Nov 5, 2025$2.32$2.43+4.92%-5.71%Preview
Q2-2025Aug 6, 2025ProPreview
Q1-2025May 7, 2025ProPreview
Q4-2024Feb 19, 2025ProPreview
Q3-2024Nov 6, 2024ProPreview
Q2-2024Aug 7, 2024ProPreview
Q1-2024May 9, 2024ProPreview
Q4-2023Feb 14, 2024ProPreview
Q3-2023Nov 8, 2023ProPreview
Q2-2023Aug 9, 2023ProPreview
Q1-2023May 11, 2023ProPreview
Q4-2022Feb 22, 2023ProPreview
Q3-2022Nov 2, 2022ProPreview
Q2-2022Aug 3, 2022ProPreview
Q1-2022May 4, 2022ProPreview
Q4-2021Feb 16, 2022ProPreview
Q3-2021Nov 3, 2021ProPreview
Q2-2021Aug 4, 2021ProPreview
Q1-2021May 4, 2021ProPreview
Q4-2020Feb 17, 2021ProPreview
Q3-2020Oct 29, 2020ProPreview
Q2-2020Aug 5, 2020ProPreview
Q1-2020May 7, 2020ProPreview
Q4-2019Feb 11, 2020ProPreview
Q3-2019Nov 6, 2019ProPreview
Q2-2019Jul 31, 2019ProPreview
Q1-2019May 7, 2019ProPreview
Q4-2018Feb 13, 2019ProPreview
Q3-2018Nov 7, 2018ProPreview
Q2-2018Aug 8, 2018ProPreview
Q1-2018May 10, 2018ProPreview
Q4-2017Feb 13, 2018ProPreview
Q3-2017Nov 9, 2017ProPreview
Q2-2017Aug 9, 2017ProPreview
Q1-2017May 10, 2017ProPreview
Q4-2016Feb 14, 2017ProPreview
Q3-2016Nov 2, 2016ProPreview
Q2-2016Aug 3, 2016ProPreview
Q1-2016May 4, 2016ProPreview
Q4-2015Feb 10, 2016ProPreview
Q3-2015Nov 4, 2015ProPreview
Q2-2015Jul 30, 2015ProPreview
Q1-2015Apr 29, 2015ProPreview
Q4-2014Feb 10, 2015ProPreview
Q3-2014Oct 29, 2014ProPreview
Q2-2014Aug 6, 2014ProPreview
Q1-2014Apr 30, 2014ProPreview
Q4-2013Feb 11, 2014ProPreview
Q3-2013Oct 29, 2013ProPreview
Q2-2013Jul 31, 2013ProPreview
Q1-2013May 1, 2013ProPreview
Q4-2012Feb 13, 2013ProPreview
Q3-2012Oct 30, 2012ProPreview
Q2-2012Aug 7, 2012ProPreview
Q1-2012May 2, 2012ProPreview
Q4-2011Feb 13, 2012ProPreview
Q3-2011Nov 1, 2011ProPreview
Q2-2011Aug 2, 2011ProPreview
Q1-2011May 3, 2011ProPreview
Q4-2010Feb 8, 2011ProPreview
Q3-2010Nov 3, 2010ProPreview
Q2-2010Aug 2, 2010ProPreview
Q1-2010Apr 26, 2010ProPreview
Q4-2009Feb 8, 2010ProPreview
Q3-2009Nov 3, 2009ProPreview
Q2-2009Aug 4, 2009ProPreview
Q1-2009May 5, 2009ProPreview
Q4-2008Feb 9, 2009ProPreview
Q3-2008Nov 5, 2008ProPreview
Q2-2008Aug 5, 2008ProPreview
Q1-2008May 6, 2008ProPreview
Q4-2007Feb 11, 2008ProPreview
Q3-2007Nov 5, 2007ProPreview

Next report

Q3-2026

Wed, Nov 4

Before the open

Est. EPS

—

Est. Rev

—

Read the preview

About CRL

Sector
Health Care
Industry
Life Sciences Tools & Services
Market cap
$14.2B

72 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Aug 6, 2025ProPreview
Q1-2025May 7, 2025ProPreview
Q4-2024Feb 19, 2025Pro
Preview
Q3-2024Nov 6, 2024ProPreview
Q2-2024Aug 7, 2024ProPreview
Q1-2024May 9, 2024ProPreview
Q4-2023Feb 14, 2024ProPreview
Q3-2023Nov 8, 2023ProPreview
Q2-2023Aug 9, 2023ProPreview
Q1-2023May 11, 2023ProPreview
Q4-2022Feb 22, 2023ProPreview
Q3-2022Nov 2, 2022ProPreview
Q2-2022Aug 3, 2022ProPreview
Q1-2022May 4, 2022ProPreview
Q4-2021Feb 16, 2022ProPreview
Q3-2021Nov 3, 2021ProPreview
Q2-2021Aug 4, 2021ProPreview
Q1-2021May 4, 2021ProPreview
Q4-2020Feb 17, 2021ProPreview
Q3-2020Oct 29, 2020ProPreview
Q2-2020Aug 5, 2020ProPreview
Q1-2020May 7, 2020ProPreview
Q4-2019Feb 11, 2020ProPreview
Q3-2019Nov 6, 2019ProPreview
Q2-2019Jul 31, 2019ProPreview
Q1-2019May 7, 2019ProPreview
Q4-2018Feb 13, 2019ProPreview
Q3-2018Nov 7, 2018ProPreview
Q2-2018Aug 8, 2018ProPreview
Q1-2018May 10, 2018ProPreview
Q4-2017Feb 13, 2018ProPreview
Q3-2017Nov 9, 2017ProPreview
Q2-2017Aug 9, 2017ProPreview
Q1-2017May 10, 2017ProPreview
Q4-2016Feb 14, 2017ProPreview
Q3-2016Nov 2, 2016ProPreview
Q2-2016Aug 3, 2016ProPreview
Q1-2016May 4, 2016ProPreview
Q4-2015Feb 10, 2016ProPreview
Q3-2015Nov 4, 2015ProPreview
Q2-2015Jul 30, 2015ProPreview
Q1-2015Apr 29, 2015ProPreview
Q4-2014Feb 10, 2015ProPreview
Q3-2014Oct 29, 2014ProPreview
Q2-2014Aug 6, 2014ProPreview
Q1-2014Apr 30, 2014ProPreview
Q4-2013Feb 11, 2014ProPreview
Q3-2013Oct 29, 2013ProPreview
Q2-2013Jul 31, 2013ProPreview
Q1-2013May 1, 2013ProPreview
Q4-2012Feb 13, 2013ProPreview
Q3-2012Oct 30, 2012ProPreview
Q2-2012Aug 7, 2012ProPreview
Q1-2012May 2, 2012ProPreview
Q4-2011Feb 13, 2012ProPreview
Q3-2011Nov 1, 2011ProPreview
Q2-2011Aug 2, 2011ProPreview
Q1-2011May 3, 2011ProPreview
Q4-2010Feb 8, 2011ProPreview
Q3-2010Nov 3, 2010ProPreview
Q2-2010Aug 2, 2010ProPreview
Q1-2010Apr 26, 2010ProPreview
Q4-2009Feb 8, 2010ProPreview
Q3-2009Nov 3, 2009ProPreview
Q2-2009Aug 4, 2009ProPreview
Q1-2009May 5, 2009ProPreview
Q4-2008Feb 9, 2009ProPreview
Q3-2008Nov 5, 2008ProPreview
Q2-2008Aug 5, 2008ProPreview
Q1-2008May 6, 2008ProPreview
Q4-2007Feb 11, 2008ProPreview
Q3-2007Nov 5, 2007ProPreview